Clinical trials
Phase 3 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
235 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 7 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 5 |
| 2007 | 7 |
| 2008 | 6 |
| 2009 | 10 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 9 |
| 2014 | 2 |
| 2015 | 8 |
| 2016 | 7 |
| 2017 | 7 |
| 2018 | 14 |
| 2019 | 13 |
| 2020 | 12 |
| 2021 | 13 |
| 2022 | 10 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 15 |
| 2026 | 18 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 96 |
| Recruiting | 38 |
| Unknown status | 32 |
| Active, not recruiting | 27 |
| Terminated | 23 |
| Not yet recruiting | 10 |
| Withdrawn | 8 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 11 |
| Gynecologic Oncology Group | 8 |
| AGO Study Group | 7 |
| Medical Research Council | 7 |
| Merck Sharp & Dohme LLC | 6 |
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Genmab | 5 |
| Hoffmann-La Roche | 5 |
| National Cancer Institute (NCI) | 5 |
| National Cancer Institute, Naples | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 235 |
| Fallopian Tube Neoplasms | 78 |
| Carcinoma, Ovarian Epithelial | 55 |
| Neoplasms | 13 |
| Peritoneal Neoplasms | 13 |
| Breast Neoplasms | 12 |
| Endometrial Neoplasms | 12 |
| Brenner Tumor | 9 |
| Recurrence | 9 |
| Uterine Cervical Neoplasms | 9 |
Trials
Showing 26 to 50 of 235. Each trial links to its page on Pharma Observatory.
135 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.